Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Interest & Investment Income (2024 - 2026)

Beta Bionics' Interest & Investment Income history spans 3 years, with the latest figure at $2.4 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 2.46% to $2.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.9 million, a 108.84% increase, with the full-year FY2025 number at $10.9 million, up 179.66% from a year prior.
  • Interest & Investment Income hit $2.4 million in Q1 2026 for Beta Bionics, down from $2.7 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for BBNX hit a ceiling of $3.0 million in Q2 2025 and a floor of $826000.0 in Q3 2024.
  • Historically, Interest & Investment Income has averaged $1.9 million across 3 years, with a median of $2.4 million in 2026.
  • Biggest five-year swings in Interest & Investment Income: surged 242.98% in 2025 and later fell 2.46% in 2026.
  • Tracing BBNX's Interest & Investment Income over 3 years: stood at $951000.0 in 2024, then skyrocketed by 179.5% to $2.7 million in 2025, then fell by 10.61% to $2.4 million in 2026.
  • Business Quant data shows Interest & Investment Income for BBNX at $2.4 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.